Oakworth Capital’s Transmedics TMDX Stock Holding History

Oakworth Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37K	Hold	372	–	–	﹤0.01%	494
2025 Q4	$45.3K	Hold	372	–	–	﹤0.01%	447
2025 Q3	$41.7K	Hold	372	–	–	﹤0.01%	462
2025 Q2	$49.9K	Hold	372	–	–	﹤0.01%	352
2025 Q1	$25K	Hold	372	–	–	﹤0.01%	438
2024 Q4	$23.2K	Sell	372 -40	-10%	-$3.72K	﹤0.01%	445
2024 Q3	$64.7K	Hold	412	–	–	﹤0.01%	333
2024 Q2	$62.1K	Hold	412	–	–	﹤0.01%	317
2024 Q1	$30.5K	Hold	412	–	–	﹤0.01%	380
2023 Q4	$32.5K	Hold	412	–	–	﹤0.01%	368
2023 Q3	$22.6K	Hold	412	–	–	﹤0.01%	376
2023 Q2	$34.6K	Hold	412	–	–	﹤0.01%	346
2023 Q1	$31.2K	Hold	412	–	–	﹤0.01%	344
2022 Q4	$25.4K	Buy	+412	New	+$21.9K	﹤0.01%	341

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oakworth Capital's TMDX Position: Q1 2026 in Review

Oakworth Capital held its Transmedics (TMDX) position steady in Q1 2026 at 372 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

Oakworth Capital first reported a position in TMDX in Q4 2022 and has held it in 14 quarters since. The position peaked at $64.7K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Oakworth Capital held 372 shares of Transmedics worth $37K as of Q1 2026.
Oakworth Capital left its Transmedics share count unchanged in Q1 2026.
Transmedics made up ﹤0.01% of Oakworth Capital's portfolio in Q1 2026, its #494 holding.
Oakworth Capital first reported a position in Transmedics in Q4 2022 and has held it in 14 quarters since.
Oakworth Capital's Transmedics position peaked at $64.7K in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Oakworth Capital's 13F filing for Q1 2026, filed 24 Apr 2026.